168 related articles for article (PubMed ID: 7594335)
21. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
Ye BD; Cheon JH; Choi KD; Kim SG; Kim JS; Jung HC; Song IS
Aliment Pharmacol Ther; 2006 Sep; 24(5):837-43. PubMed ID: 16918888
[TBL] [Abstract][Full Text] [Related]
22. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
[TBL] [Abstract][Full Text] [Related]
23. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
[TBL] [Abstract][Full Text] [Related]
24. Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study.
Kim YJ; Cheon JH; Lee SK; Kim JH; Lee YC
J Korean Med Sci; 2010 Apr; 25(4):583-8. PubMed ID: 20358002
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
Asaki S; Sato A; Sakurada H; Takeda T; Hongo M; Toyota T
J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342
[TBL] [Abstract][Full Text] [Related]
26. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
Inatomi N; Nagaya H; Takami K; Shino A; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):437-51. PubMed ID: 1886289
[TBL] [Abstract][Full Text] [Related]
27. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
[TBL] [Abstract][Full Text] [Related]
28. Mucosal regeneration of gastric ulcer confirmed by electronic endoscopy.
Hoshihara Y; Hashimoto M; Yamamoto T; Tanaka T; Iguchi D; Kimura T; Sugawara K; Fukuchi S; Takemoto T
J Clin Gastroenterol; 1995; 20 Suppl 1():S10-6. PubMed ID: 7673608
[TBL] [Abstract][Full Text] [Related]
29. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
Barradell LB; Faulds D; McTavish D
Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
[TBL] [Abstract][Full Text] [Related]
30. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
[TBL] [Abstract][Full Text] [Related]
31. A trial of lansoprazole in refractory gastric ulcer.
van Rensburg CJ; Louw JA; Girdwood AH; Simjee AE; Marks IN
Aliment Pharmacol Ther; 1996 Jun; 10(3):381-6. PubMed ID: 8791967
[TBL] [Abstract][Full Text] [Related]
32. Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
Kaneko E; Hoshihara Y; Sakaki N; Harasawa S; Ashida K; Asaka M; Asaki S; Nakamura T; Kobayashi K; Kajiyama G; Ogawa N; Yao T; Muto Y; Nakazawa S; Takemoto T
J Gastroenterol; 2000; 35(11):824-31. PubMed ID: 11085491
[TBL] [Abstract][Full Text] [Related]
33. [Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
Murakami I; Asano S; Yukishige K; Nagaya H; Satoh H; Inatomi N
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):323-32. PubMed ID: 9017686
[TBL] [Abstract][Full Text] [Related]
34. Rapid healing of gastric ulcers with lansoprazole.
Bardhan KD; Ahlberg J; Hislop WS; Lindholmer C; Long RG; Morgan AG; Sjostedt S; Smith PM; Stig R; Wormsley KG
Aliment Pharmacol Ther; 1994 Apr; 8(2):215-20. PubMed ID: 8038354
[TBL] [Abstract][Full Text] [Related]
35. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
Haga Y; Nakatsura T; Shibata Y; Sameshima H; Nakamura Y; Tanimura M; Ogawa M
Dig Dis Sci; 1998 Feb; 43(2):253-7. PubMed ID: 9512115
[No Abstract] [Full Text] [Related]
36. Factors affecting quality of ulcer healing after lansoprazole treatment.
Ito G; Nakagawara M; Watanabe F; Ooi S; Nawano M; Hanai H; Kaneko E
J Clin Gastroenterol; 1995; 20 Suppl 2():S62-6. PubMed ID: 7594344
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
[TBL] [Abstract][Full Text] [Related]
38. Increased immunoreactivity and concentration of basic fibroblast growth factor in lansoprazole-treated gastric mucosa.
Nakamura M; Oda M; Akiba Y; Inoue J; Ito T; Tsuchiya M; Ishii H
J Clin Gastroenterol; 1995; 21 Suppl 1():S24-9. PubMed ID: 8774986
[TBL] [Abstract][Full Text] [Related]
39. Lansoprazole versus famotidine in symptomatic reflux esophagitis: a randomized, multicenter study.
Umeda N; Miki K; Hoshino E
J Clin Gastroenterol; 1995; 20 Suppl 1():S17-23. PubMed ID: 7673609
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]